Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Uncategorized

Viral vector manufacturer Vibalogics adds CEO to lead expansion, COVID-19 response

Viral vector manufacturer Vibalogics adds CEO to lead expansion, COVID-19 response kblankenship Mon, 09/21/2020 – 19:14

September 22, 2020 Uncategorized

SINUS SEVERE (acetaminophen, guaifenesin, and phenylephrine hydrochloride) tablet, coated [CHAIN DRUG CONSORTIUM]

Updated Date: Mon, 14 Sep 2020 00:00:00 EDT

September 22, 2020 Uncategorized

NITYR (nitisinone) tablet [Cycle Pharmaceuticals Ltd.]

Updated Date: Mon, 14 Sep 2020 00:00:00 EDT

September 22, 2020 Uncategorized

Why have we been slow to act on air pollution as a public health issue?

Holst and colleagues discuss the asthma risk to children of being exposed to fine particular matter (PM2.5).1 Their […]

September 21, 2020 Uncategorized

ESMO: Roche, after Tecentriq’s ovarian cancer fail, banks hopes on final survival analysis

ESMO: Roche, after Tecentriq’s ovarian cancer fail, banks hopes on final survival analysis aliu Sun, 09/20/2020 – 07:45

September 21, 2020 Uncategorized

ESMO: Merck’s Keytruda doubles 5-year survival rate for lung cancer patients

ESMO: Merck’s Keytruda doubles 5-year survival rate for lung cancer patients chelfand Mon, 09/21/2020 – 02:00

September 21, 2020 Uncategorized

FiercePharmaPolitics—White House, pharma pricing talks fell apart over demand for ‘Trump Cards’: NYT

FiercePharmaPolitics—White House, pharma pricing talks fell apart over demand for ‘Trump Cards’: NYT esagonowsky Mon, 09/21/2020 – 09:51

September 21, 2020 Uncategorized

Chinese customs raids J&J CAR-T partner Legend’s office, puts new CEO under ‘residential surveillance’

Chinese customs raids J&J CAR-T partner Legend’s office, puts new CEO under ‘residential surveillance’ aliu Mon, 09/21/2020 – […]

September 21, 2020 Uncategorized

ESMO: Merck’s Keytruda pushes for 2nd esophageal cancer nod with first-line survival win

ESMO: Merck’s Keytruda pushes for 2nd esophageal cancer nod with first-line survival win chelfand Mon, 09/21/2020 – 12:25

September 21, 2020 Uncategorized

No benefit for PORT in non-small-cell lung cancer

Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant […]

September 21, 2020 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 1,361 1,362 1,363 … 1,578 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy